A federal judge tripled damages against the pharmacy benefits manager after finding it encouraged inflated Medicare drug ...

Wes Streeting has walked away from talks with pharmaceutical giants on NHS drug costs amid a stand-off over rebates. The ...

The Emeryville, California-based biotech has just released topline results from a phase 1/2 head-to-head study comparing its ...

The thyroid gland disorder treatments market is witnessing substantial growth, fueled by the increasing incidence of conditions like hypothyroidism and hyperthyroidism. Greater awareness about the ...

The pharmaceutical drug delivery market is entering a transformative phase, projected to grow from USD 1,949.4 billion in ...

Influenza Pipeline Summary. DelveInsight’s Influenza Emerging Drugs report highlights innovative therapies advancing the ...

The global Zoonotic Disease Treatment Market, valued at USD 46.4 billion in 2025, is projected to grow to USD 82.3 billion by ...

Investors are increasingly turning to ‘safer’ MNC pharma stocks with a domestic focus at a time when the Trump administration ...

In a study published in Nature, a global team of researchers developed a new technology called pathology-oriented multiplexing, or PathoPlex, to map more than 140 different proteins across 40 tissue ...

Pfizer's inclacumab fails Phase III study for sickle cell disease, disappointing the community while the company remains ...

AbbVie unveiled a $195 million investment to expand active pharmaceutical ingredient manufacturing in the U.S. Bloomberg reported that BlinkRx, a company that has Donald Trump Jr. on its board, just ...

The global Musculoskeletal Oncology Therapeutics Market is projected to grow from USD 2.2 billion in 2025 to USD 3.3 billion ...